Maplight Therapeutics, Inc. · NASDAQ:MPLT

Lillie James Woodruff sold 51,707 Maplight Therapeutics, Inc. shares (Form 4)

Traded May 4 to May 6, 2026 · Filed May 6, 2026

From May 4 to May 6, 2026, Lillie James Woodruff (Chief Scientific Officer) sold 51,707 Maplight Therapeutics, Inc. shares at an average US$28.40 for US$1.47M under a trading plan, leaving 243,450 shares. Filed May 6, 2026 (Form 4).

Sold
51,707 shares
Price
US$28.40 average (US$27.50 to US$30.08)
Value
US$1.47M
Holding after
243,450 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Scientific Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 4, 2026Voting Common StockSale9,250US$27.50285,907Direct
May 4, 2026Voting Common StockSale5,526US$28.37280,381Direct
May 4, 2026Voting Common StockSale320US$29.56280,061Direct
May 4, 2026Voting Common StockSale705US$30.08279,356Direct
May 5, 2026Voting Common StockSale10,132US$28.12269,224Direct
May 5, 2026Voting Common StockSale963US$29.00268,261Direct
May 6, 2026Voting Common StockSale8,390US$28.04259,871Direct
May 6, 2026Voting Common StockSale16,421US$29.13243,450Direct

Source

View original at SEC

Related